Cargando…
Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts
This policy research aims to map patient access barriers to biologic treatments, to explore how increased uptake of biosimilars may lower these hurdles and to identify factors limiting the increased utilisation of biosimilars. A policy survey was developed to review these questions in 10 Central and...
Autores principales: | Inotai, Andras, Csanadi, Marcell, Petrova, Guenka, Dimitrova, Maria, Bochenek, Tomasz, Tesar, Tomas, York, Kristina, Fuksa, Leos, Kostyuk, Alexander, Lorenzovici, Laszlo, Omelyanovskiy, Vitaly, Egyed, Katalin, Kalo, Zoltan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818964/ https://www.ncbi.nlm.nih.gov/pubmed/29546072 http://dx.doi.org/10.1155/2018/9597362 |
Ejemplares similares
-
Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
por: Kawalec, Paweł, et al.
Publicado: (2017) -
Potential Cost-Savings From the Use of the Biosimilars in Slovakia
por: Tesar, Tomas, et al.
Publicado: (2020) -
Development of transferability guidance for integrated care models with special focus on Central and Eastern European countries
por: Kaló, Zoltán, et al.
Publicado: (2020) -
Cost Assessment of Inpatient Care Episodes of Stroke in Romania
por: Lorenzovici, László, et al.
Publicado: (2020) -
Burden of Chronic Heart Failure in Romania
por: Lorenzovici, László, et al.
Publicado: (2022)